Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT03332797. IPD Sharing: NO. Countries: 5. Publications: 2.
Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
ClinicalTrials.gov study NCT03870399. IPD Sharing: NO. Countries: 2. Publications: 22.
Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
ClinicalTrials.gov study NCT01710605. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02221999. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT01924078. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)
ClinicalTrials.gov study NCT02730923. IPD Sharing: Not stated. Countries: 1. Publications: 49.
Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT02562118. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT03775525. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-re
ClinicalTrials.gov study NCT05128773. IPD Sharing: YES. Countries: 2. Publications: 0.
A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2
ClinicalTrials.gov study NCT03906669. IPD Sharing: NO. Countries: 1. Publications: 2.
Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT03176238. IPD Sharing: YES. Countries: 13. Publications: 0.
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
ClinicalTrials.gov study NCT01273168. IPD Sharing: YES. Countries: 1. Publications: 1.
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
ClinicalTrials.gov study NCT01197170. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer
ClinicalTrials.gov study NCT05840211. IPD Sharing: NO. Countries: 28. Publications: 1.
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer
ClinicalTrials.gov study NCT03081234. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Gr
ClinicalTrials.gov study NCT05365178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
ClinicalTrials.gov study NCT03809988. IPD Sharing: YES. Countries: 6. Publications: 1.
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer
ClinicalTrials.gov study NCT02690480. IPD Sharing: NO. Countries: 2. Publications: 2.
Effects of Pregnane X Receptor (PXR) Activation on Human Glucose, Lipid and Hormone Homeostasis
ClinicalTrials.gov study NCT01293422. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06112379. IPD Sharing: YES. Countries: 26. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.